US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rallybio Corp.

0.6260

+0.03205.39%

Volume:477.37K

Turnover:300.12K

Market Cap:26.16M

PE:-0.67

High:0.6500

Open:0.5910

Low:0.5900

Close:0.5940

52wk High:1.25

52wk Low:0.2201

Shares:41.79M

Float Shares:19.86M

Volume Ratio:0.96

T/O Rate:2.40%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.9313

EPS(LYR):-1.3268

ROE:-66.12%

ROA:-36.34%

PB:0.57

PE(LYR):-0.47

Loading ...

Overview Company News Filings

TD Cowen Reaffirms Their Buy Rating on Rallybio (RLYB)

Rallybio Corporation Reports Q2 2025 Financial Results

Rallybio Q2 EPS $(0.22) Beats $(0.24) Estimate, Sales $212.000K Down From $299.000K YoY

Rallybio Q2 revenue falls, net loss narrows

Rallybio Corp: Cash Runway Extended Into Mid-2027

THOMSON REUTERS

Rallybio Q2 Net Income USD -9.703 Million

THOMSON REUTERS

Rallybio Q2 Operating Expenses USD 10.269 Million

THOMSON REUTERS

Sector Update: Health Care Stocks Advance in Afternoon Trading

MT Newswires Live

Here's Why Shares in Recursion Pharmaceuticals Surged Today

Rallybio Stock (RLYB) Rockets 25% on a Recursion Pharmaceuticals Agreement

Rallybio Corporation Divests Interest in REV102 Program to Recursion Pharmaceuticals for Up to $25 Million

Recursion Pharmaceuticals Announces Acquisition of Full Rights to REV102, Aiming to Launch First Oral Therapy for Hypophosphatasia by 2026

ImmunoPrecise Antibodies Appoints Jon Lieber to Board of Directors, Strengthening Strategic Leadership

Rallybio Finalizes Employment Agreement with CMO

Rallybio Corporation Announces New Employment Agreement with Chief Medical Officer, Steven Ryder, Including Enhanced Compensation and Benefits Package

Rallybio’s Phase 2 Study on RLYB212: A Potential Game-Changer for Pregnant Women at Risk

BRIEF-Rallybio Initiates Dosing In RLYB116 Phase 1 Confirmatory Study

Rallybio Corporation Announces Initiation of Phase 1 Study for RLYB116, Targeting Immune PTR and Refractory APS

Rallybio Corporation Conducted Annual Shareholders Meeting

Rallybio Q1 EPS $(0.21) Beats $(0.26) Estimate, Sales $212.00K

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RLYB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RLYB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RLYB\",,,,,undefined,":{"symbol":"RLYB","market":"US","secType":"STK","nameCN":"Rallybio Corp.","latestPrice":0.626,"timestamp":1755892800000,"preClose":0.594,"halted":0,"volume":477372,"delay":0,"floatShares":19859434,"shares":41786471,"eps":-0.931323,"marketStatus":"Pre-Mkt","change":0.032,"latestTime":"08-25 07:21:55 EDT","open":0.591,"high":0.65,"low":0.59,"amount":300119.8142124,"amplitude":0.10101,"askPrice":0.6907,"askSize":100,"bidPrice":0.5725,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.931323,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1756128600000},"marketStatusCode":1,"adr":0,"listingDate":1627531200000,"exchange":"NASDAQ","adjPreClose":0.626,"postHourTrading":{"tag":"盘后","latestPrice":0.6239,"preClose":0.626,"latestTime":"18:01 EDT","volume":5611,"amount":3500.566,"timestamp":1755900117836},"volumeRatio":0.9590478227986005},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RLYB\",,,,,undefined,":{"symbol":"RLYB","floatShares":19859434,"roa":"-36.34%","roe":"-66.12%","lyrEps":-1.326793,"volumeRatio":0.9590478227986005,"shares":41786471,"dividePrice":0,"high":0.65,"amplitude":0.10101,"preClose":0.594,"low":0.59,"week52Low":0.2201,"pbRate":"0.57","psRate":"34.37","week52High":1.25,"institutionHeld":0,"latestPrice":0.626,"eps":-0.931323,"divideRate":0,"volume":477372,"delay":0,"ttmEps":-0.931323,"open":0.591,"prevYearClose":0.96,"prevWeekClose":0.626,"prevMonthClose":0.465,"prevQuarterClose":0.338,"fiveDayClose":0.604,"twentyDayClose":0.4987,"sixtyDayClose":0.337},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RLYB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-09-09","symbol":"RLYB","fiscalQuarterEnding":"2021/06","expectedEps":-4.31,"name":null,"time":"","type":"earning","dateTimestamp":1631160000000,"reportTimeType":"","actualEps":-2.8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RLYB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RLYB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.25,"hold":0.75,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.75,"analysts":4,"updateTime":1744689600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RLYB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RLYB","date":"2025-08-22","current":-0.595918,"percent":0.830875,"low":-20.977129,"twenty":-6.694439,"median":-2.833963,"eighty":-0.617701,"high":-0.180061,"avg":-3.720402,"sd":3.710778,"marketCap":24821163},"quantilePoints":[{"date":"2021-07-30","current":-14.79868,"twenty":-8.728378,"median":-3.374487,"eighty":-2.067465,"marketCap":530399490},{"date":"2021-08-06","current":-16.844456,"twenty":-17.308821,"median":-16.136253,"eighty":-3.635892,"marketCap":603722136},{"date":"2021-08-13","current":-15.329441,"twenty":-16.984303,"median":-15.885245,"eighty":-10.751812,"marketCap":549422487},{"date":"2021-08-20","current":-11.376059,"twenty":-16.839077,"median":-15.329441,"eighty":-11.49977,"marketCap":407729319},{"date":"2021-08-27","current":-11.653961,"twenty":-16.588068,"median":-13.585829,"eighty":-11.528457,"marketCap":417689610},{"date":"2021-09-03","current":-12.640065,"twenty":-16.251,"median":-12.640065,"eighty":-11.5428,"marketCap":453032577},{"date":"2021-09-10","current":-8.705446,"twenty":-15.935447,"median":-11.78843,"eighty":-11.485427,"marketCap":366281658},{"date":"2021-09-17","current":-9.7669,"twenty":-15.530248,"median":-11.752571,"eighty":-9.757736,"marketCap":410942316},{"date":"2021-09-24","current":-10.614536,"twenty":-15.356335,"median":-11.653961,"eighty":-9.395773,"marketCap":446606583},{"date":"2021-10-01","current":-14.951986,"twenty":-15.178459,"median":-11.712231,"eighty":-9.540864,"marketCap":629104812},{"date":"2021-10-08","current":-13.53926,"twenty":-14.92755,"median":-11.7705,"eighty":-9.757736,"marketCap":569664368},{"date":"2021-10-15","current":-11.851625,"twenty":-14.854009,"median":-11.820028,"eighty":-10.008209,"marketCap":498657134},{"date":"2021-10-22","current":-12.393807,"twenty":-14.792802,"median":-12.042534,"eighty":-10.437372,"marketCap":521469413},{"date":"2021-10-29","current":-13.630896,"twenty":-14.768713,"median":-12.206716,"eighty":-10.568718,"marketCap":573519964},{"date":"2021-11-05","current":-14.783986,"twenty":-14.768713,"median":-12.393807,"eighty":-10.626754,"marketCap":622036219},{"date":"2021-11-12","current":-10.682453,"twenty":-14.651113,"median":-12.551464,"eighty":-10.66003,"marketCap":481949550},{"date":"2021-11-19","current":-9.649816,"twenty":-14.509077,"median":-12.355625,"eighty":-10.313981,"marketCap":435361093},{"date":"2021-11-26","current":-9.36495,"twenty":-14.501441,"median":-12.195261,"eighty":-9.754682,"marketCap":422509105},{"date":"2021-12-03","current":-8.460503,"twenty":-14.470896,"median":-11.973807,"eighty":-9.497413,"marketCap":381704043},{"date":"2021-12-10","current":-7.805312,"twenty":-14.412552,"median":-11.78843,"eighty":-9.392863,"marketCap":352144471},{"date":"2021-12-17","current":-7.328163,"twenty":-14.171847,"median":-11.752571,"eighty":-9.046514,"marketCap":330617391},{"date":"2021-12-23","current":-8.154272,"twenty":-14.142532,"median":-11.67189,"eighty":-8.688395,"marketCap":367888156},{"date":"2021-12-31","current":-6.79404,"twenty":-14.137151,"median":-11.546386,"eighty":-8.460503,"marketCap":306519913},{"date":"2022-01-07","current":-7.057541,"twenty":-13.982169,"median":-11.488116,"eighty":-8.197002,"marketCap":318408002},{"date":"2022-01-14","current":-6.316891,"twenty":-13.93993,"median":-11.057444,"eighty":-7.66288,"marketCap":284992833},{"date":"2022-01-21","current":-6.551905,"twenty":-13.900412,"median":-10.645081,"eighty":-7.483415,"marketCap":295595724},{"date":"2022-01-28","current":-8.560206,"twenty":-13.866096,"median":-10.454172,"eighty":-7.265492,"marketCap":386202239},{"date":"2022-02-04","current":-10.376223,"twenty":-13.676714,"median":-10.27652,"eighty":-7.318193,"marketCap":468133662},{"date":"2022-02-11","current":-9.920438,"twenty":-13.618678,"median":-10.137648,"eighty":-7.379438,"marketCap":447570482},{"date":"2022-02-18","current":-9.194031,"twenty":-13.554533,"median":-9.920438,"eighty":-7.483415,"marketCap":414797912},{"date":"2022-02-25","current":-8.246854,"twenty":-13.470533,"median":-9.899073,"eighty":-7.548934,"marketCap":372065052},{"date":"2022-03-04","current":-7.043297,"twenty":-13.308923,"median":-9.754134,"eighty":-7.460625,"marketCap":317765403},{"date":"2022-03-11","current":-7.093149,"twenty":-13.072611,"median":-9.699667,"eighty":-7.199973,"marketCap":320014501},{"date":"2022-03-18","current":-5.658955,"twenty":-12.939042,"median":-9.525188,"eighty":-7.113089,"marketCap":266044431},{"date":"2022-03-25","current":-4.756802,"twenty":-12.874897,"median":-9.400355,"eighty":-7.043297,"marketCap":223631551},{"date":"2022-04-01","current":-5.248885,"twenty":-12.803115,"median":-9.378834,"eighty":-6.966384,"marketCap":246765849},{"date":"2022-04-08","current":-5.563272,"twenty":-12.766461,"median":-9.194031,"eighty":-6.876651,"marketCap":261546095},{"date":"2022-04-14","current":-6.171541,"twenty":-12.740924,"median":-9.165545,"eighty":-6.694337,"marketCap":290142659},{"date":"2022-04-22","current":-6.909666,"twenty":-12.683095,"median":-9.063555,"eighty":-6.671809,"marketCap":324844106},{"date":"2022-04-29","current":-6.807148,"twenty":-12.569184,"median":-8.809463,"eighty":-6.652689,"marketCap":320024461},{"date":"2022-05-06","current":-7.408583,"twenty":-12.43524,"median":-8.674152,"eighty":-6.633855,"marketCap":348299714},{"date":"2022-05-13","current":-7.307338,"twenty":-12.378534,"median":-8.581571,"eighty":-6.633855,"marketCap":352476740},{"date":"2022-05-20","current":-7.333982,"twenty":-12.300643,"median":-8.464063,"eighty":-6.633855,"marketCap":353761979},{"date":"2022-05-27","current":-8.659562,"twenty":-12.209006,"median":-8.493031,"eighty":-6.652689,"marketCap":417702610},{"date":"2022-06-03","current":-6.168272,"twenty":-12.189152,"median":-8.560206,"eighty":-6.651322,"marketCap":297532782},{"date":"2022-06-10","current":-4.749436,"twenty":-12.14028,"median":-8.464063,"eighty":-6.604891,"marketCap":229093816},{"date":"2022-06-17","current":-4.796065,"twenty":-12.015043,"median":-8.432016,"eighty":-6.435838,"marketCap":231342984},{"date":"2022-06-24","current":-5.328961,"twenty":-11.90508,"median":-8.3608,"eighty":-6.316891,"marketCap":257047760},{"date":"2022-07-01","current":-5.022546,"twenty":-11.851625,"median":-8.221928,"eighty":-6.168272,"marketCap":242267513},{"date":"2022-07-08","current":-5.941791,"twenty":-11.801069,"median":-8.093739,"eighty":-5.939897,"marketCap":286608252},{"date":"2022-07-15","current":-6.108321,"twenty":-11.774086,"median":-7.826677,"eighty":-5.86809,"marketCap":294640994},{"date":"2022-07-22","current":-6.32148,"twenty":-11.7705,"median":-7.756161,"eighty":-5.899528,"marketCap":304922905},{"date":"2022-07-29","current":-6.214901,"twenty":-11.741814,"median":-7.66288,"eighty":-5.923774,"marketCap":299781950},{"date":"2022-08-05","current":-7.493851,"twenty":-11.698784,"median":-7.541812,"eighty":-5.931551,"marketCap":361473412},{"date":"2022-08-12","current":-6.92084,"twenty":-11.661133,"median":-7.493851,"eighty":-5.939897,"marketCap":378514606},{"date":"2022-08-19","current":-7.179344,"twenty":-11.596587,"median":-7.451217,"eighty":-5.991189,"marketCap":392652673},{"date":"2022-08-26","current":-6.46846,"twenty":-11.553558,"median":-7.355596,"eighty":-6.037071,"marketCap":353772989},{"date":"2022-09-02","current":-6.756338,"twenty":-11.539214,"median":-7.31775,"eighty":-6.058842,"marketCap":369517655},{"date":"2022-09-09","current":-7.296845,"twenty":-11.515906,"median":-7.302091,"eighty":-6.065888,"marketCap":399079067},{"date":"2022-09-16","current":-8.154607,"twenty":-11.485427,"median":-7.333982,"eighty":-6.070353,"marketCap":445991743},{"date":"2022-09-23","current":-7.990104,"twenty":-11.415503,"median":-7.373926,"eighty":-6.093667,"marketCap":436994792},{"date":"2022-09-30","current":-8.501236,"twenty":-11.18489,"median":-7.493851,"eighty":-6.137576,"marketCap":464949605},{"date":"2022-10-07","current":-6.46846,"twenty":-10.849542,"median":-7.40042,"eighty":-6.163795,"marketCap":353772989},{"date":"2022-10-14","current":-5.111317,"twenty":-10.693848,"median":-7.337971,"eighty":-6.070353,"marketCap":279548139},{"date":"2022-10-21","current":-4.629561,"twenty":-10.66003,"median":-7.31775,"eighty":-5.97884,"marketCap":253199923},{"date":"2022-10-28","current":-5.663574,"twenty":-10.626754,"median":-7.278311,"eighty":-5.894061,"marketCap":309752190},{"date":"2022-11-04","current":-5.064316,"twenty":-10.568718,"median":-7.241138,"eighty":-5.661726,"marketCap":276977581},{"date":"2022-11-11","current":-3.293093,"twenty":-10.441003,"median":-7.203548,"eighty":-5.624408,"marketCap":207023598},{"date":"2022-11-18","current":-3.310766,"twenty":-10.372592,"median":-7.178608,"eighty":-5.549603,"marketCap":208134637},{"date":"2022-11-25","current":-3.44626,"twenty":-10.332711,"median":-7.151435,"eighty":-5.474685,"marketCap":216652603},{"date":"2022-12-02","current":-3.478912,"twenty":-10.230942,"median":-7.121635,"eighty":-5.380918,"marketCap":218705298},{"date":"2022-12-09","current":-2.967308,"twenty":-10.142633,"median":-7.09671,"eighty":-5.323318,"marketCap":186542754},{"date":"2022-12-16","current":-3.521044,"twenty":-10.064295,"median":-7.057541,"eighty":-5.272456,"marketCap":221353978},{"date":"2022-12-23","current":-3.460856,"twenty":-9.963168,"median":-7.043297,"eighty":-5.198268,"marketCap":217570150},{"date":"2022-12-30","current":-3.954404,"twenty":-9.919014,"median":-7.007689,"eighty":-5.131346,"marketCap":248597545},{"date":"2023-01-06","current":-3.689573,"twenty":-9.913316,"median":-6.977327,"eighty":-5.075835,"marketCap":231948699},{"date":"2023-01-13","current":-3.713649,"twenty":-9.899073,"median":-6.957507,"eighty":-5.022546,"marketCap":233462230},{"date":"2023-01-20","current":-4.18914,"twenty":-9.793335,"median":-6.92223,"eighty":-4.93391,"marketCap":263354477},{"date":"2023-01-27","current":-4.237291,"twenty":-9.758692,"median":-6.909666,"eighty":-4.865459,"marketCap":266381540},{"date":"2023-02-03","current":-3.882177,"twenty":-9.75263,"median":-6.889162,"eighty":-4.811295,"marketCap":244056951},{"date":"2023-02-10","current":-4.128951,"twenty":-9.721454,"median":-6.863377,"eighty":-4.767737,"marketCap":259570648},{"date":"2023-02-17","current":-4.24331,"twenty":-9.702516,"median":-6.820964,"eighty":-4.700608,"marketCap":266759923},{"date":"2023-02-24","current":-4.646575,"twenty":-9.669756,"median":-6.79404,"eighty":-4.674042,"marketCap":292111575},{"date":"2023-03-03","current":-4.772971,"twenty":-9.602813,"median":-6.726963,"eighty":-4.686296,"marketCap":300057615},{"date":"2023-03-10","current":-3.010403,"twenty":-9.515929,"median":-6.694337,"eighty":-4.656335,"marketCap":200655376},{"date":"2023-03-17","current":-2.621964,"twenty":-9.44044,"median":-6.658995,"eighty":-4.618893,"marketCap":174764360},{"date":"2023-03-24","current":-2.599114,"twenty":-9.406134,"median":-6.649955,"eighty":-4.52379,"marketCap":173241359},{"date":"2023-03-31","current":-3.261746,"twenty":-9.396204,"median":-6.619308,"eighty":-4.240902,"marketCap":217408387},{"date":"2023-04-06","current":-2.907581,"twenty":-9.39315,"median":-6.598374,"eighty":-4.203585,"marketCap":193801872},{"date":"2023-04-14","current":-2.480398,"twenty":-9.381611,"median":-6.551905,"eighty":-4.167004,"marketCap":165328417},{"date":"2023-04-21","current":-2.514376,"twenty":-9.336464,"median":-6.515058,"eighty":-4.137378,"marketCap":167593190},{"date":"2023-04-28","current":-3.063687,"twenty":-9.253853,"median":-6.48021,"eighty":-4.098857,"marketCap":204207017},{"date":"2023-05-05","current":-3.120317,"twenty":-9.191183,"median":-6.458252,"eighty":-3.992925,"marketCap":207981639},{"date":"2023-05-12","current":-2.781859,"twenty":-9.178364,"median":-6.409472,"eighty":-3.894215,"marketCap":193266856},{"date":"2023-05-19","current":-3.227391,"twenty":-9.162696,"median":-6.364777,"eighty":-3.718464,"marketCap":224219752},{"date":"2023-05-26","current":-3.346924,"twenty":-9.138483,"median":-6.32148,"eighty":-3.699846,"marketCap":232524187},{"date":"2023-06-02","current":-4.123888,"twenty":-9.105366,"median":-6.303957,"eighty":-3.69059,"marketCap":286503016},{"date":"2023-06-09","current":-4.254288,"twenty":-9.085879,"median":-6.250069,"eighty":-3.697251,"marketCap":295562400},{"date":"2023-06-16","current":-4.004355,"twenty":-9.051095,"median":-6.214901,"eighty":-3.708834,"marketCap":278198581},{"date":"2023-06-23","current":-4.286888,"twenty":-9.018537,"median":-6.181579,"eighty":-3.713649,"marketCap":297827246},{"date":"2023-06-30","current":-3.037225,"twenty":-8.999407,"median":-6.168272,"eighty":-3.693639,"marketCap":211008150},{"date":"2023-07-07","current":-3.194791,"twenty":-8.885511,"median":-6.108321,"eighty":-3.645033,"marketCap":221954906},{"date":"2023-07-14","current":-3.200224,"twenty":-8.810785,"median":-6.07002,"eighty":-3.548731,"marketCap":222332380},{"date":"2023-07-21","current":-3.224674,"twenty":-8.762004,"median":-6.045454,"eighty":-3.516182,"marketCap":224031014},{"date":"2023-07-28","current":-3.238257,"twenty":-8.715413,"median":-5.937057,"eighty":-3.480529,"marketCap":224974700},{"date":"2023-08-04","current":-3.151324,"twenty":-8.695215,"median":-5.904996,"eighty":-3.443904,"marketCap":218935111},{"date":"2023-08-11","current":-3.001727,"twenty":-8.671303,"median":-5.831884,"eighty":-3.403845,"marketCap":211684793},{"date":"2023-08-18","current":-2.932044,"twenty":-8.659701,"median":-5.658955,"eighty":-3.353507,"marketCap":206770682},{"date":"2023-08-25","current":-3.001727,"twenty":-8.659562,"median":-5.632046,"eighty":-3.303697,"marketCap":211684793},{"date":"2023-09-01","current":-2.851641,"twenty":-8.659562,"median":-5.616573,"eighty":-3.261002,"marketCap":201100553},{"date":"2023-09-08","current":-2.84092,"twenty":-8.65348,"median":-5.563272,"eighty":-3.251297,"marketCap":200344536},{"date":"2023-09-15","current":-2.709595,"twenty":-8.619242,"median":-5.485131,"eighty":-3.229564,"marketCap":191083327},{"date":"2023-09-22","current":-2.562188,"twenty":-8.573025,"median":-5.467589,"eighty":-3.225252,"marketCap":180688091},{"date":"2023-09-29","current":-1.951123,"twenty":-8.557768,"median":-5.38225,"eighty":-3.216524,"marketCap":137595115},{"date":"2023-10-06","current":-2.010085,"twenty":-8.551762,"median":-5.328961,"eighty":-3.207705,"marketCap":141753210},{"date":"2023-10-13","current":-1.918961,"twenty":-8.529437,"median":-5.319882,"eighty":-3.202398,"marketCap":135327064},{"date":"2023-10-20","current":-1.814437,"twenty":-8.498886,"median":-5.276223,"eighty":-3.193835,"marketCap":127955897},{"date":"2023-10-27","current":-2.010085,"twenty":-8.496536,"median":-5.269944,"eighty":-3.187141,"marketCap":141753210},{"date":"2023-11-03","current":-2.203053,"twenty":-8.493497,"median":-5.232654,"eighty":-3.129918,"marketCap":155361518},{"date":"2023-11-10","current":-1.629417,"twenty":-8.472705,"median":-5.181818,"eighty":-3.081778,"marketCap":114914602},{"date":"2023-11-17","current":-1.063743,"twenty":-8.461927,"median":-5.116891,"eighty":-3.056891,"marketCap":75020504},{"date":"2023-11-24","current":-1.307574,"twenty":-8.44405,"median":-5.089157,"eighty":-3.04118,"marketCap":92216640},{"date":"2023-12-01","current":-1.023552,"twenty":-8.432442,"median":-5.029207,"eighty":-3.010403,"marketCap":72185976},{"date":"2023-12-08","current":-1.468341,"twenty":-8.412802,"median":-5.010421,"eighty":-3.001727,"marketCap":103554751},{"date":"2023-12-15","current":-1.747004,"twenty":-8.376477,"median":-4.948168,"eighty":-2.978142,"marketCap":123207478},{"date":"2023-12-22","current":-1.398675,"twenty":-8.306424,"median":-4.921642,"eighty":-2.958985,"marketCap":98641570},{"date":"2023-12-29","current":-1.339727,"twenty":-8.26551,"median":-4.902644,"eighty":-2.938715,"marketCap":94484262},{"date":"2024-01-05","current":-1.152165,"twenty":-8.251518,"median":-4.864415,"eighty":-2.929466,"marketCap":81256465},{"date":"2024-01-12","current":-1.02891,"twenty":-8.229457,"median":-4.862677,"eighty":-2.909999,"marketCap":72563913},{"date":"2024-01-19","current":-0.819913,"twenty":-8.208244,"median":-4.815103,"eighty":-2.897739,"marketCap":57824368},{"date":"2024-01-26","current":-0.750247,"twenty":-8.18919,"median":-4.790102,"eighty":-2.866627,"marketCap":52911187},{"date":"2024-02-02","current":-0.728812,"twenty":-8.166357,"median":-4.772971,"eighty":-2.852152,"marketCap":51399438},{"date":"2024-02-09","current":-0.916373,"twenty":-8.154406,"median":-4.753119,"eighty":-2.84092,"marketCap":64627235},{"date":"2024-02-16","current":-0.996757,"twenty":-8.150947,"median":-4.72263,"eighty":-2.826077,"marketCap":70296291},{"date":"2024-02-23","current":-0.98068,"twenty":-8.102521,"median":-4.706764,"eighty":-2.810609,"marketCap":69162480},{"date":"2024-03-01","current":-1.245946,"twenty":-8.02181,"median":-4.700403,"eighty":-2.76064,"marketCap":87870364},{"date":"2024-03-08","current":-0.996757,"twenty":-7.998872,"median":-4.68151,"eighty":-2.689357,"marketCap":70296291},{"date":"2024-03-15","current":-0.808837,"twenty":-7.985404,"median":-4.640556,"eighty":-2.630215,"marketCap":60310092},{"date":"2024-03-22","current":-0.831656,"twenty":-7.961904,"median":-4.629561,"eighty":-2.582249,"marketCap":62011630},{"date":"2024-03-28","current":-0.806301,"twenty":-7.933704,"median":-4.60289,"eighty":-2.560182,"marketCap":60121032},{"date":"2024-04-05","current":-0.80123,"twenty":-7.909029,"median":-4.578487,"eighty":-2.513618,"marketCap":59742912},{"date":"2024-04-12","current":-1.65651,"twenty":-7.858718,"median":-4.502122,"eighty":-2.482663,"marketCap":123516032},{"date":"2024-04-19","current":-0.928313,"twenty":-7.825253,"median":-4.346654,"eighty":-2.284529,"marketCap":69218716},{"date":"2024-04-26","current":-0.917195,"twenty":-7.816707,"median":-4.314054,"eighty":-2.164459,"marketCap":68389749},{"date":"2024-05-03","current":-1.017253,"twenty":-7.80232,"median":-4.286888,"eighty":-2.025849,"marketCap":75850449},{"date":"2024-05-10","current":-1.032472,"twenty":-7.773684,"median":-4.254288,"eighty":-1.992932,"marketCap":78751832},{"date":"2024-05-17","current":-1.01076,"twenty":-7.702457,"median":-4.234281,"eighty":-1.93397,"marketCap":77095692},{"date":"2024-05-24","current":-0.874905,"twenty":-7.679972,"median":-4.199955,"eighty":-1.887336,"marketCap":66733368},{"date":"2024-05-31","current":-0.90751,"twenty":-7.66288,"median":-4.183121,"eighty":-1.827837,"marketCap":69220325},{"date":"2024-06-07","current":-0.80426,"twenty":-7.608224,"median":-4.167489,"eighty":-1.747004,"marketCap":61344959},{"date":"2024-06-14","current":-0.839583,"twenty":-7.578849,"median":-4.153027,"eighty":-1.629108,"marketCap":64039163},{"date":"2024-06-21","current":-0.793392,"twenty":-7.577706,"median":-4.13497,"eighty":-1.55837,"marketCap":60515973},{"date":"2024-06-28","current":-0.728182,"twenty":-7.57742,"median":-4.120401,"eighty":-1.512284,"marketCap":55542057},{"date":"2024-07-05","current":-0.722747,"twenty":-7.564177,"median":-4.103222,"eighty":-1.446905,"marketCap":55127565},{"date":"2024-07-12","current":-0.749918,"twenty":-7.525862,"median":-4.091848,"eighty":-1.38367,"marketCap":57200029},{"date":"2024-07-19","current":-0.728182,"twenty":-7.506204,"median":-4.027531,"eighty":-1.329009,"marketCap":55542057},{"date":"2024-07-26","current":-0.73905,"twenty":-7.498792,"median":-3.966322,"eighty":-1.286138,"marketCap":56371043},{"date":"2024-08-02","current":-0.684708,"twenty":-7.44269,"median":-3.912612,"eighty":-1.249161,"marketCap":52226114},{"date":"2024-08-09","current":-0.640163,"twenty":-7.398787,"median":-3.890256,"eighty":-1.201467,"marketCap":47295848},{"date":"2024-08-16","current":-0.617701,"twenty":-7.37026,"median":-3.822351,"eighty":-1.136089,"marketCap":45636344},{"date":"2024-08-23","current":-0.634547,"twenty":-7.345021,"median":-3.725686,"eighty":-1.071782,"marketCap":46880972},{"date":"2024-08-30","current":-0.645778,"twenty":-7.335578,"median":-3.701143,"eighty":-1.065351,"marketCap":47710723},{"date":"2024-09-06","current":-0.617701,"twenty":-7.331654,"median":-3.671517,"eighty":-1.055889,"marketCap":45636344},{"date":"2024-09-13","current":-0.634547,"twenty":-7.319833,"median":-3.641422,"eighty":-1.034656,"marketCap":46880972},{"date":"2024-09-20","current":-0.617701,"twenty":-7.303141,"median":-3.579431,"eighty":-1.025479,"marketCap":45636344},{"date":"2024-09-27","current":-0.620508,"twenty":-7.289431,"median":-3.522844,"eighty":-1.017253,"marketCap":45843782},{"date":"2024-10-04","current":-0.623316,"twenty":-7.27127,"median":-3.515989,"eighty":-1.000165,"marketCap":46051220},{"date":"2024-10-11","current":-0.617701,"twenty":-7.256981,"median":-3.509007,"eighty":-0.99423,"marketCap":45636344},{"date":"2024-10-18","current":-0.628932,"twenty":-7.243188,"median":-3.469884,"eighty":-0.98068,"marketCap":46466096},{"date":"2024-10-25","current":-0.578392,"twenty":-7.224218,"median":-3.44626,"eighty":-0.967249,"marketCap":42732213},{"date":"2024-11-01","current":-0.567162,"twenty":-7.209949,"median":-3.423988,"eighty":-0.953857,"marketCap":41902461},{"date":"2024-11-08","current":-0.619467,"twenty":-7.193866,"median":-3.393241,"eighty":-0.930599,"marketCap":41487586},{"date":"2024-11-15","current":-0.614202,"twenty":-7.17905,"median":-3.361225,"eighty":-0.916373,"marketCap":41134941},{"date":"2024-11-22","current":-0.631857,"twenty":-7.178608,"median":-3.346924,"eighty":-0.906651,"marketCap":42317337},{"date":"2024-11-29","current":-0.724777,"twenty":-7.177709,"median":-3.310766,"eighty":-0.902792,"marketCap":48540475},{"date":"2024-12-06","current":-0.656635,"twenty":-7.165043,"median":-3.269019,"eighty":-0.890221,"marketCap":43976841},{"date":"2024-12-13","current":-0.669025,"twenty":-7.128299,"median":-3.259885,"eighty":-0.874905,"marketCap":44806592},{"date":"2024-12-20","current":-0.588494,"twenty":-7.125501,"median":-3.251841,"eighty":-0.864036,"marketCap":39413206},{"date":"2024-12-27","current":-0.566131,"twenty":-7.121635,"median":-3.23622,"eighty":-0.851941,"marketCap":37915504},{"date":"2025-01-03","current":-0.625662,"twenty":-7.120986,"median":-3.230107,"eighty":-0.845956,"marketCap":41902461},{"date":"2025-01-10","current":-0.582299,"twenty":-7.108492,"median":-3.227391,"eighty":-0.836866,"marketCap":38998330},{"date":"2025-01-17","current":-0.542158,"twenty":-7.095997,"median":-3.224674,"eighty":-0.829864,"marketCap":36309935},{"date":"2025-01-24","current":-0.545131,"twenty":-7.080239,"median":-3.2201,"eighty":-0.823542,"marketCap":36509075},{"date":"2025-01-31","current":-0.53268,"twenty":-7.05954,"median":-3.21633,"eighty":-0.810366,"marketCap":35675175},{"date":"2025-02-07","current":-0.523016,"twenty":-7.051843,"median":-3.210776,"eighty":-0.805076,"marketCap":35027968},{"date":"2025-02-14","current":-0.466769,"twenty":-7.043297,"median":-3.205658,"eighty":-0.795566,"marketCap":31260896},{"date":"2025-02-21","current":-0.467078,"twenty":-7.043297,"median":-3.202941,"eighty":-0.783611,"marketCap":31281639},{"date":"2025-02-28","current":-0.447441,"twenty":-7.040448,"median":-3.19891,"eighty":-0.762966,"marketCap":29966483},{"date":"2025-03-07","current":-0.460884,"twenty":-7.020508,"median":-3.190735,"eighty":-0.755353,"marketCap":30866763},{"date":"2025-03-14","current":-0.455194,"twenty":-6.985247,"median":-3.167624,"eighty":-0.746342,"marketCap":26298808},{"date":"2025-03-21","current":-0.482563,"twenty":-6.979494,"median":-3.129253,"eighty":-0.743666,"marketCap":27880066},{"date":"2025-03-28","current":-0.461028,"twenty":-6.971841,"median":-3.108932,"eighty":-0.737543,"marketCap":26635866},{"date":"2025-04-04","current":-0.324109,"twenty":-6.962974,"median":-3.064039,"eighty":-0.728182,"marketCap":18725417},{"date":"2025-04-11","current":-0.180277,"twenty":-6.9533,"median":-3.058024,"eighty":-0.722888,"marketCap":10415493},{"date":"2025-04-17","current":-0.180061,"twenty":-6.936473,"median":-3.046698,"eighty":-0.717313,"marketCap":10403009},{"date":"2025-04-25","current":-0.21845,"twenty":-6.92223,"median":-3.038094,"eighty":-0.706445,"marketCap":12620931},{"date":"2025-05-02","current":-0.228317,"twenty":-6.92084,"median":-3.010403,"eighty":-0.702017,"marketCap":13191016},{"date":"2025-05-09","current":-0.253043,"twenty":-6.909666,"median":-3.003208,"eighty":-0.695577,"marketCap":12192891},{"date":"2025-05-16","current":-0.30227,"twenty":-6.909666,"median":-3.001727,"eighty":-0.681414,"marketCap":14564887},{"date":"2025-05-23","current":-0.284998,"twenty":-6.907986,"median":-2.984306,"eighty":-0.669025,"marketCap":13732608},{"date":"2025-05-30","current":-0.275498,"twenty":-6.892927,"median":-2.971117,"eighty":-0.665994,"marketCap":13274854},{"date":"2025-06-06","current":-0.292943,"twenty":-6.881432,"median":-2.961158,"eighty":-0.655729,"marketCap":14115456},{"date":"2025-06-13","current":-0.28517,"twenty":-6.873802,"median":-2.940681,"eighty":-0.651203,"marketCap":13740930},{"date":"2025-06-20","current":-0.281629,"twenty":-6.861577,"median":-2.932044,"eighty":-0.648576,"marketCap":13570313},{"date":"2025-06-27","current":-0.313065,"twenty":-6.846383,"median":-2.910603,"eighty":-0.640163,"marketCap":15085061},{"date":"2025-07-03","current":-0.287329,"twenty":-6.833018,"median":-2.910603,"eighty":-0.638896,"marketCap":13844965},{"date":"2025-07-11","current":-0.341997,"twenty":-6.815438,"median":-2.900875,"eighty":-0.634547,"marketCap":16479129},{"date":"2025-07-18","current":-0.392692,"twenty":-6.801905,"median":-2.879658,"eighty":-0.628932,"marketCap":18921869},{"date":"2025-07-25","current":-0.452542,"twenty":-6.78601,"median":-2.866354,"eighty":-0.624254,"marketCap":21805717},{"date":"2025-08-01","current":-0.401587,"twenty":-6.766914,"median":-2.854156,"eighty":-0.623316,"marketCap":19350493},{"date":"2025-08-08","current":-0.510533,"twenty":-6.732838,"median":-2.851641,"eighty":-0.623316,"marketCap":21264735},{"date":"2025-08-15","current":-0.547763,"twenty":-6.696356,"median":-2.84092,"eighty":-0.619883,"marketCap":22815413},{"date":"2025-08-22","current":-0.595918,"twenty":-6.694439,"median":-2.833963,"eighty":-0.617701,"marketCap":24821163}],"updateTime":1756106794424},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RLYB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2558365636","title":"TD Cowen Reaffirms Their Buy Rating on Rallybio (RLYB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2558365636","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558365636?lang=en_us&edition=fundamental","pubTime":"2025-08-11 12:15","pubTimestamp":1754885726,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Ritu Baral maintained a Buy rating on Rallybio today. The company’s shares closed last Friday at $0.53. According to TipRanks, Bar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-reaffirms-their-buy-rating-on-rallybio-rlyb-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-reaffirms-their-buy-rating-on-rallybio-rlyb-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RLYB","COWN","TD"],"gpt_icon":0},{"id":"2557109405","title":"Rallybio Corporation Reports Q2 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2557109405","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557109405?lang=en_us&edition=fundamental","pubTime":"2025-08-08 13:58","pubTimestamp":1754632727,"startTime":"0","endTime":"0","summary":"Rallybio Corporation ( ($RLYB) ) has released its Q2 earnings. Here is a breakdown of the information Rallybio Corporation presented to its investo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rallybio-corporation-reports-q2-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rallybio-corporation-reports-q2-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","RLYB","BK4139"],"gpt_icon":0},{"id":"2557682075","title":"Rallybio Q2 EPS $(0.22) Beats $(0.24) Estimate, Sales $212.000K Down From $299.000K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2557682075","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557682075?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:09","pubTimestamp":1754568599,"startTime":"0","endTime":"0","summary":"Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.24) by 10.2 percent. This is a 40.54 percent increase over losses of $(0.37) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46959482/rallybio-q2-eps-0-22-beats-0-24-estimate-sales-212-000k-down-from-299-000k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLYB"],"gpt_icon":0},{"id":"2557856872","title":"Rallybio Q2 revenue falls, net loss narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2557856872","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557856872?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:09","pubTimestamp":1754568592,"startTime":"0","endTime":"0","summary":"Rallybio Q2 revenue falls, net loss narrowsOverviewRallybio Q2 revenue dips to $0.2 mln from $0.3 mln in 2024Net loss narrows to $9.7 mln from $16.2 mln in Q2 2024Co sells REV102 interest for up to $2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX95E5C2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLYB","JNJ"],"gpt_icon":1},{"id":"2557684975","title":"Rallybio Corp: Cash Runway Extended Into Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2557684975","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557684975?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:00","pubTimestamp":1754568000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX95E5C2:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLYB","BK4539","BK4139"],"gpt_icon":0},{"id":"2557568547","title":"Rallybio Q2 Net Income USD -9.703 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557568547","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557568547?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:00","pubTimestamp":1754568000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX95E5C2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLYB","BK4139","BK4539"],"gpt_icon":0},{"id":"2557568300","title":"Rallybio Q2 Operating Expenses USD 10.269 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557568300","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557568300?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:00","pubTimestamp":1754568000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX95E5C2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RLYB","BK4139","BK4539"],"gpt_icon":0},{"id":"2550522050","title":"Sector Update: Health Care Stocks Advance in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2550522050","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550522050?lang=en_us&edition=fundamental","pubTime":"2025-07-09 01:57","pubTimestamp":1751997449,"startTime":"0","endTime":"0","summary":"Health care stocks rose Tuesday afternoon with the NYSE Health Care Index gaining 0.3% and the Health Care Select Sector SPDR Fund  adding 0.5%.The iShares Biotechnology ETF  climbed 1.3%.In corporate news, Recursion Pharmaceuticals  shares jumped 11% after the company gained full rights to REV102, a drug candidate for hypophosphatasia, after acquiring Rallybio's  interest in the program. Rallybio surged 43%.Pfizer  Chief Corporate Officer Sally Susman will leave the company at the end of the year. Pfizer shares rose 1.1%.ProKidney  shares soared more than sixfold after the company said its investigational therapy rilparencel stabilized kidney function in a group of patients with chronic kidney disease and diabetes who received two injections about three months apart in a phase 2 trial, replicating the dosing regimen of its ongoing phase 3 study.Maze Therapeutics'  development strategy using genetic validation is seen as promising in terms of its target identification strategy and appl","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BLSP4452.SGD","LU0321505439.SGD","IE00BBT3K403.USD","LU0225771236.USD","PFE.AU","MAZE","BK4533","LU1023059063.AUD","SG9999001176.USD","BK4568","LU0321505868.SGD","BK4588","SG9999003800.SGD","LU0225284248.USD","LU0868494617.USD","BK4534","SGXZ57979304.SGD","BK4007","LU0456855351.SGD","IE0002270589.USD","IE00B19Z3581.USD","LU1883839398.USD","RLYB","SG9999001176.SGD","LU1066053197.SGD","LU1066051498.USD","BK4139","LU1057294990.SGD","IE00B19Z3B42.SGD","LU1894683348.USD","SG9999002232.USD","BK4592","BK4539","SG9999013999.USD","BK4550","BK4581","SG9999002224.SGD","LU0306806265.USD","LU0058720904.USD","LU1894683264.USD","LU0170899867.USD","LU0985481810.HKD","PROK","RXRX","IBB","XLV","SG9999011175.SGD","LU0289739699.SGD"],"gpt_icon":1},{"id":"2550452294","title":"Here's Why Shares in Recursion Pharmaceuticals Surged Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2550452294","media":"Motley Fool","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550452294?lang=en_us&edition=fundamental","pubTime":"2025-07-09 01:28","pubTimestamp":1751995680,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals is now the sole owner of a drug in its pipeline.The deal de-risks the company's pipeline by removing uncertainty; however, there's still a long way to go before REV102 is commercialized.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/07/08/heres-why-shares-in-recursion-pharmaceuticals-surg/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4223","HPP","BK4139","RXRX","BK4539","RLYB","BK4194"],"gpt_icon":1},{"id":"2549540746","title":"Rallybio Stock (RLYB) Rockets 25% on a Recursion Pharmaceuticals Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2549540746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549540746?lang=en_us&edition=fundamental","pubTime":"2025-07-08 21:12","pubTimestamp":1751980334,"startTime":"0","endTime":"0","summary":"Rallybio stock soared on Tuesday after the company reached an agreement with Recursion Pharmaceuticals.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/rallybio-stock-rlyb-rockets-25-on-a-recursion-pharmaceuticals-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/rallybio-stock-rlyb-rockets-25-on-a-recursion-pharmaceuticals-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4611","RXRX","BK4548","BK4609","RLYB","BK4139"],"gpt_icon":0},{"id":"2549544605","title":"Rallybio Corporation Divests Interest in REV102 Program to Recursion Pharmaceuticals for Up to $25 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2549544605","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549544605?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976038,"startTime":"0","endTime":"0","summary":"Rallybio Corporation has announced the sale of its interest in the REV102 program to Recursion Pharmaceuticals, a move anticipated to extend Rallybio's cash runway to mid-2027. The deal, valued at up to $25 million, includes an upfront equity payment of $7.5 million and additional milestone payments. The REV102 program, focused on developing an ENPP1 inhibitor for treating hypophosphatasia , originated from a joint venture between the two companies. Rallybio's CEO, Stephen Uden, expressed enthusiasm for the program's progression, highlighting the collaboration's success in advancing a potential oral disease-modifying treatment for HPP.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rallybio Corporation published the original content us","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nNDL1rRsmK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RLYB","BK4611","BK4609","RXRX","BK4539","BK4548"],"gpt_icon":1},{"id":"2549645544","title":"Recursion Pharmaceuticals Announces Acquisition of Full Rights to REV102, Aiming to Launch First Oral Therapy for Hypophosphatasia by 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2549645544","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549645544?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976034,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals Announces Acquisition of Full Rights to REV102, Aiming to Launch First Oral Therapy for Hypophosphatasia by 2026. Recursion Pharmaceuticals Inc.  has announced the acquisition of Rallybio's full interest in their joint ENPP1 inhibitor program, REV102, designed for the treatment of hypophosphatasia , a rare genetic disorder. The acquisition includes an associated backup molecule. This move grants Recursion full ownership of the program, allowing the company to expedite the development of what could become the first oral disease-modifying therapy for HPP. Currently in IND-enabling studies, REV102 is expected to enter Phase 1 clinical trials in the second half of 2026. The program aims to address the underlying cause of HPP by inhibiting the enzyme ENPP1, potentially improving bone mineralization. Results of these studies have yet to be presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nNDL5SzTHN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4611","NDAQ","IE00B64PRP62.GBP","BK4539","LU2095319765.USD","BK4548","BK4139","LU2210150020.SGD","RXRX","RLYB","BK4112","BK4588","BK4585","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4609","IE00BKPKM429.USD"],"gpt_icon":1},{"id":"2549962537","title":"ImmunoPrecise Antibodies Appoints Jon Lieber to Board of Directors, Strengthening Strategic Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2549962537","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549962537?lang=en_us&edition=fundamental","pubTime":"2025-07-07 21:00","pubTimestamp":1751893244,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies Ltd. has appointed Jon Lieber to its Board of Directors. Lieber, with over 30 years of experience in the biotechnology and life sciences sectors, currently serves as the Chief Financial Officer at Rallybio. His background includes strategic leadership roles and expertise in Nasdaq governance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ImmunoPrecise Antibodies Ltd. published the original content used to generate this news brief via Business Wire  on July 07, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nNDLVL5H4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RLYB","BK4139","BK4121","IPA"],"gpt_icon":0},{"id":"2546172190","title":"Rallybio Finalizes Employment Agreement with CMO","url":"https://stock-news.laohu8.com/highlight/detail?id=2546172190","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546172190?lang=en_us&edition=fundamental","pubTime":"2025-06-28 04:31","pubTimestamp":1751056300,"startTime":"0","endTime":"0","summary":"Rallybio ( ($RLYB) ) just unveiled an update. On June 25, 2025, Rallybio Corporation formalized an employment agreement with its Chief Medical Offi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rallybio-finalizes-employment-agreement-with-cmo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rallybio-finalizes-employment-agreement-with-cmo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","RLYB"],"gpt_icon":0},{"id":"2546172923","title":"Rallybio Corporation Announces New Employment Agreement with Chief Medical Officer, Steven Ryder, Including Enhanced Compensation and Benefits Package","url":"https://stock-news.laohu8.com/highlight/detail?id=2546172923","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546172923?lang=en_us&edition=fundamental","pubTime":"2025-06-28 04:11","pubTimestamp":1751055070,"startTime":"0","endTime":"0","summary":"Rallybio Corporation Announces New Employment Agreement with Chief Medical Officer, Steven Ryder, Including Enhanced Compensation and Benefits Package. Rallybio Corporation has announced a new employment agreement with its Chief Medical Officer, Dr. Steven Ryder, effective June 25, 2025. Under this agreement, Dr. Ryder will receive an annual base salary of $531,227 and will be eligible for an annual target bonus of up to 40% of his salary, contingent upon meeting individual and company performance goals. The agreement stipulates an initial one-year term, automatically renewing for successive one-year terms unless either party provides a 60-day notice to terminate. In the event of termination following a change in control, Dr. Ryder will be entitled to severance benefits including a 1.5 times payment of his annual salary and target bonus, plus health premium coverage, and immediate vesting of certain equity awards.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nNDL2NHZdb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","RLYB"],"gpt_icon":0},{"id":"2546409730","title":"Rallybio’s Phase 2 Study on RLYB212: A Potential Game-Changer for Pregnant Women at Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2546409730","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546409730?lang=en_us&edition=fundamental","pubTime":"2025-06-27 00:15","pubTimestamp":1750954501,"startTime":"0","endTime":"0","summary":"Rallybio Corporation (($RLYB)) announced an update on their ongoing clinical study. Rallybio Corporation is conducting a Phase 2 study titled A Pha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rallybios-phase-2-study-on-rlyb212-a-potential-game-changer-for-pregnant-women-at-risk?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rallybios-phase-2-study-on-rlyb212-a-potential-game-changer-for-pregnant-women-at-risk?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","RLYB"],"gpt_icon":0},{"id":"2542359511","title":"BRIEF-Rallybio Initiates Dosing In RLYB116 Phase 1 Confirmatory Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2542359511","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542359511?lang=en_us&edition=fundamental","pubTime":"2025-06-12 20:20","pubTimestamp":1749730854,"startTime":"0","endTime":"0","summary":"BRIEF-Rallybio Initiates Dosing In RLYB116 Phase 1 Confirmatory StudyJune 12 (Reuters) - Rallybio Corp RLYB.O:RALLYBIO INITIATES DOSING IN RLYB116 PHASE 1 CONFIRMATORY PHARMACOKINETIC/PHARMACODYNAMIC ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nFWN3SF0CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RLYB","BK4539"],"gpt_icon":0},{"id":"2542519921","title":"Rallybio Corporation Announces Initiation of Phase 1 Study for RLYB116, Targeting Immune PTR and Refractory APS","url":"https://stock-news.laohu8.com/highlight/detail?id=2542519921","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542519921?lang=en_us&edition=fundamental","pubTime":"2025-06-12 20:01","pubTimestamp":1749729667,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rallybio Corporation published the original content used to generate this news brief via Business Wire  on June 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL126llL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RLYB","BK4539"],"gpt_icon":0},{"id":"2535926013","title":"Rallybio Corporation Conducted Annual Shareholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2535926013","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535926013?lang=en_us&edition=fundamental","pubTime":"2025-05-16 20:32","pubTimestamp":1747398730,"startTime":"0","endTime":"0","summary":"Rallybio Corporation held its annual meeting of shareholders on May 13, 2025. During the meeting, Martin W. Mackay and Paula Soteropoulos were elected to the Board of Directors as Class I directors. Additionally, the shareholders ratified the appointment of Deloitte and Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Both proposals were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rallybio Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 16, 2025, and is solely responsible for the information containe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDL9jHxPr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RLYB","BK4139"],"gpt_icon":0},{"id":"2533318238","title":"Rallybio Q1 EPS $(0.21) Beats $(0.26) Estimate, Sales $212.00K","url":"https://stock-news.laohu8.com/highlight/detail?id=2533318238","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533318238?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:20","pubTimestamp":1746706823,"startTime":"0","endTime":"0","summary":"Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.26) by 19.23 percent. This is a 55.32 percent increase over losses of $(0.47) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45283470/rallybio-q1-eps-0-21-beats-0-26-estimate-sales-212-00k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLYB"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}]}}